drugset / Trial / NCT03629340
Metformin for Pulmonary Hypertension HFpEF
Phase 2
Completed
33 enrolled
University of California, San Francisco
National Institute on Aging (NIA) · collab
RandomizedCrossoverQuadruple-blindTreatment
Summary
The main objective of this study is to determine the clinical efficacy of metformin versus placebo and the therapeutic response with regards to functional capacity and hemodynamics in PH-HFpEF.
Timeline
- Start
- 2019-02-26
- Primary completion
- 2026-02-27
- Completion
- 2026-02-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 1000 mg | Oral |